Citi Pharma (KAR:CPHL) General and Admin. Expense: ₨ Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:CPHL Citi Pharma Ltd KAR:CPHL
15 GF Score
Price ₨75.08
! 1 Warning Sign
View Full Analysis

What is Citi Pharma General and Admin. Expense?

Citi Pharma KAR:CPHL +0.37% 15 General and Admin. Expense is ₨ Mil as of . 20. GuruFocus rates KAR:CPHL with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Citi Pharma's General and Admin. Expense for the six months ended in . 20 was ₨0.00 Mil. Citi Pharma does not have enough years/quarters to calculate the General and Admin. Expense for the trailing twelve months (TTM) ended in . 20.

Citi Pharma General and Admin. Expense Related Terms

Citi Pharma General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Citi Pharma's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Citi Pharma General and Admin. Expense Chart

Citi Pharma Annual Data
Trend
General and Admin. Expense

Citi Pharma Semi-Annual Data
General and Admin. Expense
KAR:CPHL
15GF Score
Citi Pharma Ltd KAR:CPHL
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Citi Pharma General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

What does a General and Admin. Expense of ₨ Mil mean?
Citi Pharma (KAR:CPHL) has a General and Admin. Expense of ₨ Mil as of . 20. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Citi Pharma and its competitors.
Is Citi Pharma's General and Admin. Expense too high?
Citi Pharma's current General and Admin. Expense is ₨ Mil. Overall, Citi Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Citi Pharma's General and Admin. Expense compare to ZTS and UTHR?
Citi Pharma's General and Admin. Expense of ₨ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Citi Pharma and its competitors. Citi Pharma's current General and Admin. Expense is ₨ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Citi Pharma stock overvalued right now?
Citi Pharma (KAR:CPHL) has a current General and Admin. Expense of ₨ Mil. The current General and Admin. Expense is ₨ Mil. Citi Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Citi Pharma (KAR:CPHL), the current General and Admin. Expense is ₨ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Citi Pharma Business Description

Address 588 Q Block, M.A., Johar Town, Lahore, PB, PAK
Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its product portfolio includes API segment, Formulation segment, Cephalosporin formulation, and Nutraceuticals. The API segment includes Paracetamol, Penicillin/Amoxicillin, Levofloxacin, Cefixime/Cephalosporin, Ciprofloxacin, Cephradine, Norfloxacin, Aspirin, and Ibuprofen.
15GF Score

Get the complete analysis for KAR:CPHL

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨75.08
Price